NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM
25/06/2021 09:01
NASDAQ TRADE HALT CONTINUES ACXP.O REASON NOT AVAILABLE AT 04:00 AM
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program